Co-Diagnostics, Inc. Common Stock (CODX) Stock Price

CODXStock

$0.65−93.77%52W

Market Cap$4.57M

P/E—

PEG Ratio—

Div yield—

Beta3.17

CODX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-62.51%

Price vs S&P 500 (4W)-33.92%

VGM Score33.02

Book Value / Share (Quarterly)$2.61

P/TBV (Annual)0.77x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-73.70%

Cash Flow / Share (Quarterly)$-5.63

Price vs S&P 500 (YTD)-99.00%

Gross Margin (TTM)43.48%

Net Profit Margin (TTM)-6523.11%

EPS (TTM)$-23.84

10-Day Avg Trading Volume0.53M

EPS Excl Extra (TTM)$-23.84

Revenue Growth (5Y)-61.60%

EPS (Annual)$-35.25

ROI (Annual)-227.33%

Gross Margin (Annual)64.28%

Net Profit Margin (5Y Avg)-1803.56%

Cash / Share (Quarterly)$0.75

Revenue Growth QoQ (YoY)1.98%

ROA (Last FY)-189.54%

Revenue Growth TTM (YoY)-28.13%

EBITD / Share (TTM)$-19.71

ROE (5Y Avg)-64.69%

Operating Margin (TTM)-6770.38%

Cash Flow / Share (Annual)$-14.24

P/B Ratio0.38x

P/B Ratio (Quarterly)0.89x

Net Income / Employee (Annual)$-407,800

EV / Revenue (TTM)1.69x

Net Interest Coverage (TTM)121.11x

ROA (TTM)-174.97%

EV / EBITDA (TTM)0.07x

EPS Incl Extra (Annual)$-35.25

Current Ratio (Annual)3.87x

Quick Ratio (Quarterly)1.29x

3-Month Avg Trading Volume0.42M

52-Week Price Return-93.77%

Revenue / Employee (TTM)$6,300

Tangible BV / Share (Quarterly)$1.13

P/S Ratio (Annual)7.82x

Asset Turnover (Annual)0.03x

52-Week High$46.50

Operating Margin (5Y Avg)-1910.89%

EPS Excl Extra (Annual)$-35.25

CapEx CAGR (5Y)-1.89%

Tangible BV CAGR (5Y)-27.45%

26-Week Price Return-52.61%

Quick Ratio (Annual)3.42x

13-Week Price Return-73.41%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)1.81x

Enterprise Value$1.22M

Revenue / Share Growth (5Y)-29.37%

Asset Turnover (TTM)0.03x

Book Value / Share Growth (5Y)33.38%

Revenue / Employee (Annual)$5,400

Inventory Turnover (Annual)0.22x

Pretax Margin (Annual)-7793.20%

Cash / Share (Annual)$5.67

3-Month Return Std Dev112.16%

Gross Margin (5Y Avg)69.90%

Net Income / Employee (TTM)$-409,200

ROE (Last FY)-227.33%

Net Interest Coverage (Annual)-530.29x

EPS Basic Excl Extra (Annual)$-35.25

P/FCF (TTM)0.34x

Receivables Turnover (TTM)5.49x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-23.84

Receivables Turnover (Annual)3.85x

ROI (TTM)-210.99%

P/S Ratio (TTM)6.75x

Pretax Margin (5Y Avg)-1864.20%

Revenue / Share (Annual)$0.47

Tangible BV / Share (Annual)$6.40

Price vs S&P 500 (52W)-109.30%

Year-to-Date Return-87.08%

5-Day Price Return-47.68%

EPS Normalized (Annual)$-35.25

ROA (5Y Avg)-54.90%

Net Profit Margin (Annual)-7533.61%

Month-to-Date Return-38.88%

Cash Flow / Share (TTM)$-1.41

EBITD / Share (Annual)$-36.27

Operating Margin (Annual)-7929.36%

ROI (5Y Avg)-64.69%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-23.84

P/TBV (Quarterly)2.06x

P/B Ratio (Annual)0.50x

Inventory Turnover (TTM)0.42x

Pretax Margin (TTM)-6747.76%

Book Value / Share (Annual)$9.85

Price vs S&P 500 (13W)-76.10%

Beta3.17x

P/FCF (Annual)0.95x

Revenue / Share (TTM)$0.17

ROE (TTM)-210.99%

52-Week Low$0.63

vGradeB

gGradeF

mGradeF

vgmGradeD

CODX Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 13, 2026	-$3.00	-$1.45	+51.63%(+$1.55)
Q1 2026	May 14, 2026	-$3.75	-$4.09	-9.05%(-$0.34)
Q4 2025	Mar 31, 2026	-$3.60	-$4.44	-23.30%(-$0.84)
Q3 2025	Nov 13, 2025	-$5.70	-$4.66	+18.21%(+$1.04)
Q2 2025	Aug 14, 2025	-$7.50	-$7.01	+6.60%(+$0.49)

CODX Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

2.29

4.00

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
CODXCo-Diagnostics, Inc. Common Stock	B	F	F	6.7x	-61.6%	43.5%	-6770.4%	$0.65
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About Co-Diagnostics, Inc. Common Stock

Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.